Fos Feminista
Fos Feminista (INNOVA)

Deal Summary

Ceniarth is providing a $1.4m loan to Fòs Feminista, a global alliance of nearly 200 partners advancing sexual and reproductive health, rights, and justice across 35 countries in the Global South. The capital will be on-lent to INNOVA Health Supplies, a social enterprise co-founded by Fòs Feminista to help grassroots, civil society, and non-governmental organizations in Latin America and the Caribbean access affordable contraceptives and other essential SRH products.

Amid major funding rollbacks from USAID and other multilateral organizations, once the largest global suppliers of contraceptives, sexual and reproductive health organizations across the region now face rising prices and procurement delays that can stretch beyond a year.

Together with co-financing from the Packard Foundation, A to Z Impact, and Fòs Feminista’s own funds, this loan supports a $3.2m pooled inventory purchase that enables INNOVA to move from just-in-time procurement to a warehousing model. By purchasing in bulk, INNOVA can avoid supply chain volatility and long delays—ensuring faster, more reliable, and affordable delivery of essential supplies to frontline organizations working to protect the health, dignity and reproductive autonomy of women and girls.

Beneficiary Impact

Fòs Feminista’s partners include small community organizations and clinics that often struggle to secure reliable contraceptive supplies due to high costs, limited purchasing power, and long procurement delays. INNOVA’s pooled purchasing model eliminates minimum order requirements and gives partners access to high-quality contraceptives, menstrual products, and other SRH supplies. By purchasing directly from major manufacturers , INNOVA removes intermediaries, secures bulk pricing below commercial distributors, and cuts delivery times from up to 13 months to just three months.

With dependable inventory and faster delivery, organizations that purchase supplies through INNOVA can plan services with confidence and maintain uninterrupted care in rural, fragile, and crisis-affected areas such as Haiti and along migrant routes. INNOVA estimates that this inventory purchase alone will help prevent 1.4 million unintended pregnancies between 2026 and 2028.

Intermediary Impact

INNOVA was co-founded as a social enterprise by Fòs Feminista and five of its partners to strengthen the reproductive health commodity ecosystem for its alliance partners, many of which are small civil society organizations working in challenging contexts. The enterprise also plays a central market-shaping role by providing the technical and regulatory expertise that grassroots groups often lack.

INNOVA works closely with national regulators and Ministries of Health to expand both legal and market access to essential sexual and reproductive health products. To date, it has secured 61 brand registrations and 12 sanitary authorizations across 12 countries, streamlining import processes and helping partners navigate customs requirements, tariffs, and product approvals. INNOVA also supports governments and civil society organizations in implementing policy changes that improve access to high-quality products and strengthen local health systems.

Capital Additionality

This investment underscores the vital role impact-first capital can play when traditional funding falls short. As major cuts from USAID and other multilateral organizations ripple through the contraceptive supply chain—and institutional and government support for women’s health declines—organizations across Latin America and the Caribbean are struggling with rising prices and limited product availability. By providing a $1.4m loan, alongside support from the Packard Foundation and A to Z Impact, Ceniarth is stepping in where capital is missing.